AR122973A1 - Compuestos de piperidina sustituida y su uso - Google Patents
Compuestos de piperidina sustituida y su usoInfo
- Publication number
- AR122973A1 AR122973A1 ARP210101982A ARP210101982A AR122973A1 AR 122973 A1 AR122973 A1 AR 122973A1 AR P210101982 A ARP210101982 A AR P210101982A AR P210101982 A ARP210101982 A AR P210101982A AR 122973 A1 AR122973 A1 AR 122973A1
- Authority
- AR
- Argentina
- Prior art keywords
- piperidine compounds
- substituted piperidine
- orextin
- pharmaceutically acceptable
- acceptable salts
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
Abstract
Se proporcionan compuestos representados por las siguientes formulas (1), (2), (3) y (4) que tienen actividad activante del receptor de orextina tipo 2, o sus sales farmacéuticamente aceptables.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020122864 | 2020-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR122973A1 true AR122973A1 (es) | 2022-10-19 |
Family
ID=79291962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210101982A AR122973A1 (es) | 2020-07-17 | 2021-07-15 | Compuestos de piperidina sustituida y su uso |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11479552B2 (es) |
| EP (1) | EP4151277A1 (es) |
| JP (1) | JP7190612B2 (es) |
| KR (1) | KR20230040953A (es) |
| CN (1) | CN115884971A (es) |
| AR (1) | AR122973A1 (es) |
| AU (1) | AU2021308053A1 (es) |
| BR (1) | BR112022026161A2 (es) |
| CA (1) | CA3187835A1 (es) |
| CL (1) | CL2022003666A1 (es) |
| CO (1) | CO2022018446A2 (es) |
| IL (1) | IL299125A (es) |
| MX (1) | MX2022016388A (es) |
| PE (1) | PE20231103A1 (es) |
| TW (1) | TW202216705A (es) |
| WO (1) | WO2022014680A1 (es) |
| ZA (1) | ZA202213562B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11542276B2 (en) | 2019-11-25 | 2023-01-03 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| WO2023136279A1 (ja) * | 2022-01-14 | 2023-07-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶 |
| WO2024075825A1 (ja) * | 2022-10-07 | 2024-04-11 | キッセイ薬品工業株式会社 | シクロペンタン化合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG34208A1 (en) | 1995-03-01 | 1996-12-06 | Guy Andrew Vaz | Blast and fragment resistant polyurethane boot sole for safety footwear |
| EP0828751A4 (en) | 1995-05-05 | 1999-01-20 | Human Genome Sciences Inc | HUMAN NEUROPEPTIDE RECEPTOR |
| US6309854B1 (en) | 1996-12-17 | 2001-10-30 | Smithkline Beecham Corporation | Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72 |
| US6159605A (en) | 1997-02-18 | 2000-12-12 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Ink-jet recording sheet |
| US5935814A (en) | 1997-04-30 | 1999-08-10 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72Y receptor |
| US6020157A (en) | 1997-04-30 | 2000-02-01 | Smithkline Beecham Corporation | Polynucleotides encoding HFGAN72X receptor |
| US6166193A (en) | 1997-07-25 | 2000-12-26 | Board Of Regents, University Of Texas System | Polynucleotides encoding MY1 receptor |
| KR100327888B1 (ko) | 1999-07-14 | 2002-03-09 | 정숭렬 | 도로포장 파손촉진 시험장치의 무선제어 시스템 |
| WO2005028438A1 (ja) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | 新規ピペリジン誘導体 |
| WO2006045716A1 (en) | 2004-10-20 | 2006-05-04 | Neurosearch A/S | Novel diazabicyclic aryl derivatives and their medical use |
| JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
| TW201444849A (zh) * | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途 |
-
2021
- 2021-07-15 US US17/376,452 patent/US11479552B2/en active Active
- 2021-07-15 WO PCT/JP2021/026649 patent/WO2022014680A1/ja active Application Filing
- 2021-07-15 PE PE2022003006A patent/PE20231103A1/es unknown
- 2021-07-15 BR BR112022026161A patent/BR112022026161A2/pt unknown
- 2021-07-15 AU AU2021308053A patent/AU2021308053A1/en active Pending
- 2021-07-15 MX MX2022016388A patent/MX2022016388A/es unknown
- 2021-07-15 TW TW110126031A patent/TW202216705A/zh unknown
- 2021-07-15 IL IL299125A patent/IL299125A/en unknown
- 2021-07-15 EP EP21842047.9A patent/EP4151277A1/en active Pending
- 2021-07-15 KR KR1020227044679A patent/KR20230040953A/ko unknown
- 2021-07-15 CA CA3187835A patent/CA3187835A1/en active Pending
- 2021-07-15 JP JP2022536446A patent/JP7190612B2/ja active Active
- 2021-07-15 CN CN202180044081.3A patent/CN115884971A/zh active Pending
- 2021-07-15 AR ARP210101982A patent/AR122973A1/es unknown
-
2022
- 2022-12-14 ZA ZA2022/13562A patent/ZA202213562B/en unknown
- 2022-12-20 CL CL2022003666A patent/CL2022003666A1/es unknown
- 2022-12-20 CO CONC2022/0018446A patent/CO2022018446A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN115884971A (zh) | 2023-03-31 |
| US20220017517A1 (en) | 2022-01-20 |
| CO2022018446A2 (es) | 2023-03-07 |
| EP4151277A1 (en) | 2023-03-22 |
| CA3187835A1 (en) | 2022-01-20 |
| AU2021308053A1 (en) | 2023-02-02 |
| JPWO2022014680A1 (es) | 2022-01-20 |
| JP7190612B2 (ja) | 2022-12-15 |
| TW202216705A (zh) | 2022-05-01 |
| KR20230040953A (ko) | 2023-03-23 |
| BR112022026161A2 (pt) | 2023-01-31 |
| US11479552B2 (en) | 2022-10-25 |
| PE20231103A1 (es) | 2023-07-19 |
| ZA202213562B (en) | 2023-10-25 |
| IL299125A (en) | 2023-02-01 |
| CL2022003666A1 (es) | 2023-05-26 |
| WO2022014680A1 (ja) | 2022-01-20 |
| MX2022016388A (es) | 2023-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR122973A1 (es) | Compuestos de piperidina sustituida y su uso | |
| CL2023003041A1 (es) | Derivados de triazina que tienen actividad inhibidora de la replicación del virus y composición farmacéutica | |
| CO2020000145A2 (es) | Carboxamidas como moduladores de los canales de sodio | |
| DOP2022000115A (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio | |
| UY37103A (es) | Compuestos de piperidina sustituido y su uso | |
| UY29267A1 (es) | Derivados de piperidina y su uso como agentes antiinflamatorios | |
| GT199900008A (es) | Compuestos 4-(2-ceto-1-benzilimidazolinil) piperidina como agonistas del receptor orl1 | |
| PA8577001A1 (es) | Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos | |
| SV2004001690A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
| PA8595901A1 (es) | "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos | |
| CR9459A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
| CO6150138A2 (es) | Ciclobuten-1,2-dionas 3,4-di-sustituidas como ligandos de receptores de quimiocinas cxc | |
| UY29633A1 (es) | Derivados de oxindol | |
| CR9078A (es) | Derivado de bencimidazol ariloxi-sustituidos | |
| AR067779A1 (es) | Profarmacos dipeptoides y su uso | |
| CY1109656T1 (el) | Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης | |
| UY30835A1 (es) | 8-alquinilxantinas y derivados | |
| CR9667A (es) | Derivados de benzamida y usos relacionados con los mismos | |
| CR10314A (es) | Compuestos que tienen actividad en el receptor m 1 y sus usos en medicina | |
| CR9722A (es) | Derivados de benzilpiperazina y su uso medico | |
| SV2004001549A (es) | Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
| CO2021001224A2 (es) | Derivados de tiadiazina | |
| AR109168A1 (es) | Sales de derivados de 2,6-dimetilpirimidona y sus usos | |
| CO2021001216A2 (es) | Derivados de espirocromano | |
| CR11584A (es) | Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina |